Abogen Biosciences Funding: $700M Raised, Series C (2021)
Abogen Biosciences is based in Suzhou, China. It has raised $700M in total funding. Latest round: Series C.
Abogen Biosciences funding overview
Abogen Biosciences is based in Suzhou, China. Abogen Biosciences has raised $700M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in August 2021. The round record for Abogen Biosciences runs through 2021; nothing later has been disclosed. Investors on record include Temasek, Invesco Developing Markets Fund, Loyal Valley Capital, GL Ventures, Yunfeng Capital, Lilly Asia Ventures and 1 others. 7 distinct backers are named across the disclosed rounds.
Abogen Biosciences at a glance
Total raised
$700M
Latest round
Series C
Latest round date
August 2021
Headquarters
Suzhou, China
Notable investors
Temasek, Invesco Developing Markets Fund, Loyal Valley Capital, GL Ventures, Yunfeng Capital, Lilly Asia Ventures, Boyu Capital
Frequently asked about Abogen Biosciences funding
How much has Abogen Biosciences raised?
Abogen Biosciences has raised $700M in total disclosed funding across the rounds on record.
Who has invested in Abogen Biosciences?
Temasek, Invesco Developing Markets Fund, Loyal Valley Capital, GL Ventures, Yunfeng Capital, Lilly Asia Ventures are named among the investors backing Abogen Biosciences.
What was the latest Abogen Biosciences funding round?
The most recent disclosed round is a Series C, announced in August 2021.
Where is Abogen Biosciences based?
Abogen Biosciences is based in Suzhou, China.
When did Abogen Biosciences last raise?
The last disclosed Abogen Biosciences round closed in August 2021 at Series C.
Abogen Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Suzhou below to benchmark round size and investor mix.
